Colorectal cancer: Future population screening for early colorectal cancer
- 作者H.E Blum
- 卷第31卷
- 印刷ISSN0959-8049
- 文件大小497.36KB
- 发表时间1995
- DOI10.1016/0959-8049(95)00215-5
同作者推荐
Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracilG.J. Peters; C.L. Van Der Wilt; F. Gyergyay; J.A.M. Van Laar; M. Treskes; W.J.F. Van Der Vijgh; H.M. Pinedo · 1992
ZD1839 (‘Iressa’), an orally-active, selective, epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki), is well tolerated in combination with gemcitabine and cisplatin, in patients with advanced solid tumours: preliminary tolerability, efficacy and pharmacokinetic resultsG. Giaccone; J.L. Gonzales-Larriba; E.F. Smit; A.T. van Oosterom; M. Martins; G.J. Peters; W.J.F. van der Vijgh; R. Smith; A. Fandi; S. Averbuch · 2001